The fact that NLRX1 deficiency specifically sensitizes transformed cells to apoptotic cell death induced by extrinsic signals, whereas NLRX1 expression sensitizes cells to intrinsic apoptosis stimuli offers promising therapeutic avenues aimed at targeting the unique property of this protein in cancer cells. Here, NLRX1 is linked to cancer.